ERBB2 and neoplasm: We found an association between HER2-low status and worse PFS and OS in two patient sub-cohorts in which HER2 status was assessed in the primary tumor (Supplementary Fig. 2, Supplementary Table 3) or in a metastatic lesion (Supplementary Fig. 3, Supplementary Table 4).